Entera Bio Ltd.

📍 Israel🗓 Founded 2010👥 18 employees💰 Last funded Sep 2018
Biotechnology🌐 enterabio.com
Website LinkedIn
Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics. Entera Bio is currently conducting clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics while enhancing their absorption in the GI tract. Entera Bio's technology addresses the two major problems of oral drug delivery of large molecule APIs (active pharmaceutical ingredients). Most large molecules cannot be administered orally as they are not readily absorbed by the gastrointestinal tract and are rapidly degraded by a myriad of enzymes and acids in the gastrointestinal tract. Entera’s Proprietary Technologies Act Synergistically to Transport and Protect Large Molecules.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2010
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Entera Bio Ltd.?
Entera Bio Ltd. has 2 investors on record on gritt.io and 2 late-stage investors.
When did Entera Bio Ltd. last raise funding?
The most recent investment in Entera Bio Ltd. recorded on gritt.io was in September 2018.
When was Entera Bio Ltd. founded?
Entera Bio Ltd. was founded in 2010.
What industry is Entera Bio Ltd. in?
Entera Bio Ltd. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Entera Bio Ltd. based?
Entera Bio Ltd. is headquartered in Israel.